Bridging bench to bedside with aneurotechnology cross-development platform
通过神经技术交叉开发平台将工作台与床边桥接起来
基本信息
- 批准号:10640424
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-02-01 至 2027-01-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAddressAffectAgeAlgorithm DesignAlgorithmsAmericanAmplifiersArchitectureBrainCapitalCaringChronicClinical ResearchCollaborationsCommunicationCommunitiesComplexComputer softwareComputersCustomDataDetectionDevelopmentDevice or Instrument DevelopmentDevicesDiseaseDrug CostsEconomic BurdenEcosystemElectrodesElectronicsElectrophysiology (science)EvaluationFeedbackFutureGoalsGrowthHealth Care CostsHuman ResourcesImplantInjuryIntellectual PropertyInterventionInvestigationInvestmentsKnowledgeLawsLiquid substanceLogicLongitudinal StudiesManufacturerMarketingMedicalMedical DeviceMissionNervous SystemNervous System TraumaNeurologicNeurologyNeurostimulation procedures of spinal cord tissueOperating SystemParkinson DiseasePatientsPersonsPharmaceutical PreparationsPharmacologic SubstancePhaseResearchResourcesRiskSensorimotor functionsServicesShapesSheepSpinalSpinal CordSpinal cord injurySystemTechnologyTelemetryTestingTextilesTherapeuticThinnessTimeTransistorsTranslationsTremorUnited States Department of Veterans AffairsUnited States Food and Drug AdministrationVertebral columnVeteransWritingbench to bedsidebioelectronicschronic paincostdata acquisitiondeep brain stimulatordensitydesignfirst-in-humanflexibilityhuman studyimplantable deviceimprovedin vivoinnovationinstrumentmanufacturemedical implantmicrochipnervous system disorderneuralneuroregulationneurotechnologynew technologynext generationnovelnovel therapeuticspharmacologicpre-clinicalpreclinical evaluationpreclinical studyprematureprogramsresearch and developmentresearch clinical testingrestorationsocioeconomicsspinal cord and brain injurysuccesstimelinetoolwireless
项目摘要
Advancements in neurotechnology are shaping the future of medical care for those suffering from neurological
illness, disease, and injury. Unfortunately, it can take decades to bring such advances from the benchtop to the
bedside in service of our Veterans. The development, evaluation, optimization, and deployment of each
subcomponent of a medical device is complex, and combinations of technologies are required to address the
complex needs of Veterans with, for example, traumatic brain and spinal cord injuries. In fact, the last major
neurotechnology translational success was arguably the deep brain stimulator (DBS) developed in the 1980’s,
delivering electrical neuromodulation to the brain to reduce Essential and Parkinson’s Disease-related tremor,
but were not approved by the Food and Drug Administration until 2002. While impressive technologies are on
the horizon, including those supported by the Department of Veterans Affairs, the time, money, and scientific
divide between benchtop successes and bedside therapeutic application is exceptionally vast. Bioelectronics
are hyped as an alternative to drug interventions, but the reality is that the translation timelines for medical
devices—and their success rates as therapeutic tools—mirror the slow and costly development of new
pharmaceuticals rather than mirroring the lean, accelerated development of new electronics for the consumer
market.
This issue matters because the socioeconomic burden of neurological injury and disorders is significant. Spinal
cord injuries (SCIs) alone are estimated to affect between 249,000 and 363,000 Americans (NSCISC), and
roughly 42,000 people with SCIs are Veterans, an estimated $5M/patient over their lifetime in health care
costs. Nearly half of all SCIs occur in people between the ages of 16 and 30, leaving many to live with the
injuries for decades. The inefficiency of bringing new drugs to market is dubbed “Eroom’s” law, given the
exponentially increasing cost of drug release—in contrast to Moore’s law, originally referring to the number of
transistors on a microchip doubling every 2 years though the cost of computers is halved, but more generally
illustrating the exponential growth for technologies over time. From a translational perspective, the efficiency of
medical device innovation still has much more in common with pharmacological research and development
(R&D) than it does with Moore’s law and consumer electronics.
We propose the development of a hardware and software accelerator platform (“cross-development”, or xDev)
for electrophysiology research and neurotechnology creation. Development of this platform would enable new
research into spinal cord stimulation for sensorimotor restoration in SCI, as well as for continued investigation
of spinal electrophysiology in closed-loop devices for chronic pain. The new tool will be used to accelerate
design, development and deployment of neurotechnology by smoothing the transition between design phases,
allowing rapid redesign and re-verification of neurotechnology components. The xDev platform maximizes the
ability of neurotechnology device developers to test their tools with versatile interfaces, algorithms, and
underlying chipsets, improving compatibility, cross-functionality, and inspiring new collaborations between
technology developers. Strategic platform organization protects neurotechnology developers’ intellectual
property, while improving modularity with tools from other manufacturers. Leveraging the xDev platform, we will
demonstrate a new neurotechnology enabling chronic recording of spinal electrophysiology and fill a
neuroscientific knowledge gap, connecting the fields of Restorative Neurology and therapeutic spinal cord
neuromodulation.
神经技术的进步正在塑造神经系统疾病患者医疗保健的未来。
疾病,疾病和伤害。不幸的是,要把这些进步从实验室带到现实生活中,
为我们的退伍军人服务。每一项的开发、评估、优化和部署
医疗器械的子组件是复杂的,需要技术的组合来解决
退伍军人的复杂需求,例如,创伤性脑损伤和脊髓损伤。事实上,最后一个主要的
神经技术转化的成功可以说是20世纪80年代开发的深部脑刺激器(DBS),
向大脑提供电神经调节,以减少原发性和帕金森病相关的震颤,
但直到2002年才被食品和药物管理局批准。虽然令人印象深刻的技术
地平线,包括那些由退伍军人事务部,时间,金钱和科学的支持,
在实验室成功和临床治疗应用之间的差距是非常巨大的。生物电子
被大肆宣传为药物干预的替代方案,但现实是,医疗翻译的时间表
设备-以及它们作为治疗工具的成功率-反映了新技术的缓慢和昂贵的发展,
制药业,而不是反映精简,加速发展的新电子产品的消费者
市场
这个问题很重要,因为神经损伤和疾病的社会经济负担很大。脊柱
据估计,仅脊髓损伤(SCI)就影响了249,000至363,000名美国人(NSCISC),
大约42,000名SCI患者是退伍军人,估计他们一生中的医疗保健费用为500万美元/患者
成本近一半的SCI发生在16至30岁的人群中,许多人生活在
几十年的伤病。将新药推向市场的低效率被称为“Eroom”定律,因为
药物释放的成本呈指数增长-与摩尔定律相反,摩尔定律最初指的是药物释放的数量。
微芯片上的晶体管每两年翻一番,尽管计算机的成本减半,但更普遍的是,
说明了随着时间的推移,技术的指数增长。从翻译的角度来看,
医疗器械创新与药理学研究和开发仍然有更多的共同点
(研发)比它与摩尔定律和消费电子产品。
我们建议开发一个硬件和软件加速器平台(“交叉开发”,或xDev)
用于电生理学研究和神经技术创造。该平台的开发将使新的
研究脊髓刺激用于SCI感觉运动恢复,以及继续研究
脊髓电生理学在慢性疼痛的闭环设备。新工具将用于加速
通过平滑设计阶段之间的过渡,设计,开发和部署神经技术,
允许快速重新设计和重新验证神经技术组件。xDev平台最大化了
神经技术设备开发人员使用通用接口、算法和
底层芯片组,提高兼容性,跨功能,并激发新的合作,
技术开发人员。战略平台组织保护神经技术开发人员的知识产权
性能,同时提高模块化与其他制造商的工具。利用xDev平台,我们将
展示了一种新的神经技术,能够长期记录脊髓电生理学,并填补了
神经科学知识的差距,连接恢复性神经病学和治疗脊髓领域
神经调节
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David Allenson Borton其他文献
David Allenson Borton的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David Allenson Borton', 18)}}的其他基金
Bioengineering a cortical microtissue model to study human microglia in Alzheimer's disease
生物工程皮质微组织模型来研究阿尔茨海默病中的人类小胶质细胞
- 批准号:
10630949 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Bioengineering a cortical microtissue model to study human microglia in Alzheimer's disease
生物工程皮质微组织模型来研究阿尔茨海默病中的人类小胶质细胞
- 批准号:
10448954 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Spatiotemporal Coding in the Pain Circuit Along the Spine-brain Continuum
沿着脊柱-大脑连续体的疼痛回路的时空编码
- 批准号:
10205394 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Accelerating Dissemination of Implantable Neurotechnology for Clinical Research
加速临床研究植入式神经技术的传播
- 批准号:
10470025 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Accelerating Dissemination of Implantable Neurotechnology for Clinical Research
加速临床研究植入式神经技术的传播
- 批准号:
10689290 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Accelerating Dissemination of Implantable Neurotechnology for Clinical Research
加速临床研究植入式神经技术的传播
- 批准号:
10238761 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Large Scale Cortical Laminar Recordings: Novel Instrumentation
大规模皮质层流记录:新颖的仪器
- 批准号:
10078368 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Spatiotemporal Coding in the Pain Circuit Along the Spine-brain Continuum
沿着脊柱-大脑连续体的疼痛回路的时空编码
- 批准号:
10305343 - 财政年份:2018
- 资助金额:
-- - 项目类别:
The Role of M1 Leg Area in Volitional and Stereotyped Control of the Lower Limb
M1 腿部区域在下肢意志和刻板控制中的作用
- 批准号:
10021472 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Spatiotemporal Coding in the Pain Circuit Along the Spine-brain Continuum
沿着脊柱-大脑连续体的疼痛回路的时空编码
- 批准号:
10267899 - 财政年份:2018
- 资助金额:
-- - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
-- - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
-- - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant